Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GK567 (topical metronidazole) in rosacea – phase 3 randomized trial
jRCT2080224617Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metronidazole in rosacea (2 arms), sponsored by Maruho Co., Ltd. Started Mar 2019; status: completed.
02
Drugs
metronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on jRCT2080224617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224617.